Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Saline for Lateral Epicondylitis
NCT05125705Phase 3Unknown
- Sponsor
- Singapore General Hospital
- Start
- Nov 2021
- Primary completion
- May 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 3, randomised, double-blind trial of platelet-rich plasma in Lateral Epicondylitis (LET) (2 arms), sponsored by Singapore General Hospital. Primary endpoints: Patient-Related Tennis Elbow Evaluation pain score at 6 months, Patient-Related Tennis Elbow Evaluation functional disability score at 6 months and 3 more. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT05125705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125705.